Vétoquinol Publishes Its Half Year Financial Report Relative to Fiscal Year 2014

Regulatory News:

Vétoquinol (Paris:VETO):

The half year financial report relative to fiscal year 2014 can be read or downloaded on the websites of:

- Vétoquinol (www.vetoquinol.com)

- the AMF (www.amf-france.org)

It is also available to the public free of charge upon simple request:

- by e-mail: relations.investisseurs@vetoquinol.com

- by phone: +33 (0)3 84 62 59 88

About Vétoquinol
Vétoquinol is an independent, family-owned business, global player in the animal health sector serving both the livestock (cattle and swine) and pet (dogs and cats) markets. Vétoquinol designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region.
Since its foundation in 1933, Vétoquinol has pursued a strategy combining innovation and geographical diversification. The Group's hybrid growth is driven by the reinforcement of its product portfolio coupled with acquisitions in high growth markets. Vétoquinol employs over 1,950 people globally.
Vétoquinol has been listed on NYSE Euronext Paris since 2006 (symbol: VETO).

For more information: www.vetoquinol.com.

OUR BUSINESS: ANIMALS. OUR ADVANTAGE: PEOPLE.

VETOQUINOL – 34 rue du Chêne Sainte Anne - Magny-Vernois – 70204 Lure Cedex – France
www.vetoquinol.com